Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00277004 · ClinicalTrials.gov registry record
Physiological Biomarkers of Cancer Treatment Related Fatigue in Women With Breast Cancer.
A clinical trial, sponsored by University of New Mexico.
- Terminated
- Registry status
- 22
- Enrollment target
NCT00277004: Clinical Trial study, sponsored by University of New Mexico.
NCT00277004 is a clinical trial that was terminated before completion, run by University of New Mexico. The registered enrollment target is 22 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00277004 was terminated before completion, sponsored by University of New Mexico.
- TERMINATED
- Registry status
- 22 participants
- Enrollment target
Study Summary
Physiological Biomarkers of Cancer Treatment Related Fatigue in Women with Breast Cancer.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 1999-02 |
| Est. Completion | 2005-03 |
Why NCT00277004 stopped before completion
NCT00277004 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 22 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00277004 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00277004 about?
NCT00277004 is a clinical study titled "Physiological Biomarkers of Cancer Treatment Related Fatigue in Women With Breast Cancer.". Physiological Biomarkers of Cancer Treatment Related Fatigue in Women with Breast Cancer.
What is the current status of trial NCT00277004?
This trial is currently terminated. The enrollment target is 22 participants. The study started on 1999-02. Estimated completion is 2005-03.
Who is sponsoring clinical trial NCT00277004?
This trial is sponsored by University of New Mexico, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02508038 · 22 participants · Phase 1
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- NCT03099356 · 22 participants · Phase 2
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
- NCT03676647 · 22 participants
Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
- NCT04569591 · 22 participants · NA
DDAVP for Pituitary Adenoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia